A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children

Recruiting N/A Interventional Study
Helicobacter Infections
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 – 18
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
1,440 (estimated)
Sponsor
Ying HUANG · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
With the resistance of Helicobacter pylori increasing, low and unsatisfactory eradication rate (64%) have been observed with standard triple therapy in European children. Which regimen is appropriate for Chinese children? There is no large scale, multi center studies in China about treatment, CYP2C19 gene polymorphism, resistance rate and resistance genotype. Investigators want to perform a resear…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * children 6-18 years of age who were referred for upper endoscopy and confirmed to have Hp infection Exclusion Criteria: * patients were excluded if they had taken proton pump inhibitors, H2-receptor antagonists or antibiotics in the 4 weeks prior to the study. Patients with …
Contacts

Ying Zhou, master

13917394900

nnyyhhs@163.com

CONTACT